开云app官网登录入口网页版-官方正版

[GetPortalCommentsPageByObjectIdResponse(id=1091044, encodeId=2729109104488, content=highlights部分的一般要求是什么？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=bb142989248, createdName=MS68862005, createdTime=Wed Dec 29 14:52:48 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1091043, encodeId=ac5710910433f, content=什么时候需要highlights部分？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=107, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=1ff65466529, createdName=ms6000000264964247, createdTime=Tue Dec 28 14:52:48 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1057075, encodeId=cf46105e07545, content=审稿速度:1.0 | 投稿命中率:50.0 偏重的研究方向：心血管研究;心律失常 经验分享：我是基础心血管药理学研究，心律失常方向。一审三周多点，两个reviews给了半年的大修，意见很细致，从实验上到文字讨论问题都提到了，并且都给出了文献引用供作者修稿时参考，问题都很专业，直击要害。我修回以后又是三周直接接收，3-5天直接预先在杂志官网online并出现DOI号，7-10天可在Pubmed检索到并出现PMID。三周以后发proof让校稿。目前等待正式上线中。是否OA可自选，价钱不便宜。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=115, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=d4215515377, createdName=ms1000001131168263, createdTime=Sun Oct 03 10:25:37 CST 2021, time=2021-10-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=544016, encodeId=1cd75440160f, content=徘徊不前,不过处于这个关口上的期刊,再往上冲已不易了,4分多,也算满意了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=374, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=wang_di98, createdTime=Sun Jul 16 19:01:00 CST 2017, time=2017-07-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=832235, encodeId=859d832235be, content=审稿速度:2.0 经验分享：已修回，但修改意见特别多，三个审稿人，都提出了大量的问题。argue了整整9页。编辑和审稿人都很负责任。作为一个临床房颤的研究，还是挺受欢迎的。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=177, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=40eb5414087, createdName=ms8415407993286297, createdTime=Tue May 24 13:38:26 CST 2016, time=2016-05-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=500345, encodeId=39a850034588, content=屡投屡拒啊，伤心，但是继续坚持！！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=408, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Wed Dec 25 14:44:00 CST 2013, time=2013-12-25, status=1, ipAttribution=)]

2021-12-29 MS68862005

highlights部分的一般要求是什么？

1 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=1091044, encodeId=2729109104488, content=highlights部分的一般要求是什么？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=bb142989248, createdName=MS68862005, createdTime=Wed Dec 29 14:52:48 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1091043, encodeId=ac5710910433f, content=什么时候需要highlights部分？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=107, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=1ff65466529, createdName=ms6000000264964247, createdTime=Tue Dec 28 14:52:48 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1057075, encodeId=cf46105e07545, content=审稿速度:1.0 | 投稿命中率:50.0 偏重的研究方向：心血管研究;心律失常 经验分享：我是基础心血管药理学研究，心律失常方向。一审三周多点，两个reviews给了半年的大修，意见很细致，从实验上到文字讨论问题都提到了，并且都给出了文献引用供作者修稿时参考，问题都很专业，直击要害。我修回以后又是三周直接接收，3-5天直接预先在杂志官网online并出现DOI号，7-10天可在Pubmed检索到并出现PMID。三周以后发proof让校稿。目前等待正式上线中。是否OA可自选，价钱不便宜。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=115, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=d4215515377, createdName=ms1000001131168263, createdTime=Sun Oct 03 10:25:37 CST 2021, time=2021-10-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=544016, encodeId=1cd75440160f, content=徘徊不前,不过处于这个关口上的期刊,再往上冲已不易了,4分多,也算满意了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=374, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=wang_di98, createdTime=Sun Jul 16 19:01:00 CST 2017, time=2017-07-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=832235, encodeId=859d832235be, content=审稿速度:2.0 经验分享：已修回，但修改意见特别多，三个审稿人，都提出了大量的问题。argue了整整9页。编辑和审稿人都很负责任。作为一个临床房颤的研究，还是挺受欢迎的。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=177, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=40eb5414087, createdName=ms8415407993286297, createdTime=Tue May 24 13:38:26 CST 2016, time=2016-05-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=500345, encodeId=39a850034588, content=屡投屡拒啊，伤心，但是继续坚持！！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=408, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Wed Dec 25 14:44:00 CST 2013, time=2013-12-25, status=1, ipAttribution=)]

2021-12-28 ms6000000264964247

什么时候需要highlights部分？

107 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=1091044, encodeId=2729109104488, content=highlights部分的一般要求是什么？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=bb142989248, createdName=MS68862005, createdTime=Wed Dec 29 14:52:48 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1091043, encodeId=ac5710910433f, content=什么时候需要highlights部分？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=107, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=1ff65466529, createdName=ms6000000264964247, createdTime=Tue Dec 28 14:52:48 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1057075, encodeId=cf46105e07545, content=审稿速度:1.0 | 投稿命中率:50.0 偏重的研究方向：心血管研究;心律失常 经验分享：我是基础心血管药理学研究，心律失常方向。一审三周多点，两个reviews给了半年的大修，意见很细致，从实验上到文字讨论问题都提到了，并且都给出了文献引用供作者修稿时参考，问题都很专业，直击要害。我修回以后又是三周直接接收，3-5天直接预先在杂志官网online并出现DOI号，7-10天可在Pubmed检索到并出现PMID。三周以后发proof让校稿。目前等待正式上线中。是否OA可自选，价钱不便宜。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=115, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=d4215515377, createdName=ms1000001131168263, createdTime=Sun Oct 03 10:25:37 CST 2021, time=2021-10-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=544016, encodeId=1cd75440160f, content=徘徊不前,不过处于这个关口上的期刊,再往上冲已不易了,4分多,也算满意了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=374, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=wang_di98, createdTime=Sun Jul 16 19:01:00 CST 2017, time=2017-07-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=832235, encodeId=859d832235be, content=审稿速度:2.0 经验分享：已修回，但修改意见特别多，三个审稿人，都提出了大量的问题。argue了整整9页。编辑和审稿人都很负责任。作为一个临床房颤的研究，还是挺受欢迎的。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=177, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=40eb5414087, createdName=ms8415407993286297, createdTime=Tue May 24 13:38:26 CST 2016, time=2016-05-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=500345, encodeId=39a850034588, content=屡投屡拒啊，伤心，但是继续坚持！！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=408, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Wed Dec 25 14:44:00 CST 2013, time=2013-12-25, status=1, ipAttribution=)]

2021-10-03 ms1000001131168263

审稿速度:1.0 | 投稿命中率:50.0
偏重的研究方向：心血管研究;心律失常
经验分享：我是基础心血管药理学研究，心律失常方向。一审三周多点，两个reviews给了半年的大修，意见很细致，从实验上到文字讨论问题都提到了，并且都给出了文献引用供作者修稿时参考，问题都很专业，直击要害。我修回以后又是三周直接接收，3-5天直接预先在杂志官网online并出现DOI号，7-10天可在Pubmed检索到并出现PMID。三周以后发proof让校稿。目前等待正式上线中。是否OA可自选，价钱不便宜。

115 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=1091044, encodeId=2729109104488, content=highlights部分的一般要求是什么？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=bb142989248, createdName=MS68862005, createdTime=Wed Dec 29 14:52:48 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1091043, encodeId=ac5710910433f, content=什么时候需要highlights部分？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=107, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=1ff65466529, createdName=ms6000000264964247, createdTime=Tue Dec 28 14:52:48 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1057075, encodeId=cf46105e07545, content=审稿速度:1.0 | 投稿命中率:50.0 偏重的研究方向：心血管研究;心律失常 经验分享：我是基础心血管药理学研究，心律失常方向。一审三周多点，两个reviews给了半年的大修，意见很细致，从实验上到文字讨论问题都提到了，并且都给出了文献引用供作者修稿时参考，问题都很专业，直击要害。我修回以后又是三周直接接收，3-5天直接预先在杂志官网online并出现DOI号，7-10天可在Pubmed检索到并出现PMID。三周以后发proof让校稿。目前等待正式上线中。是否OA可自选，价钱不便宜。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=115, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=d4215515377, createdName=ms1000001131168263, createdTime=Sun Oct 03 10:25:37 CST 2021, time=2021-10-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=544016, encodeId=1cd75440160f, content=徘徊不前,不过处于这个关口上的期刊,再往上冲已不易了,4分多,也算满意了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=374, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=wang_di98, createdTime=Sun Jul 16 19:01:00 CST 2017, time=2017-07-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=832235, encodeId=859d832235be, content=审稿速度:2.0 经验分享：已修回，但修改意见特别多，三个审稿人，都提出了大量的问题。argue了整整9页。编辑和审稿人都很负责任。作为一个临床房颤的研究，还是挺受欢迎的。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=177, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=40eb5414087, createdName=ms8415407993286297, createdTime=Tue May 24 13:38:26 CST 2016, time=2016-05-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=500345, encodeId=39a850034588, content=屡投屡拒啊，伤心，但是继续坚持！！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=408, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Wed Dec 25 14:44:00 CST 2013, time=2013-12-25, status=1, ipAttribution=)]

2017-07-16 wang_di98

徘徊不前,不过处于这个关口上的期刊,再往上冲已不易了,4分多,也算满意了

374 0

[GetPortalCommentsPageByObjectIdResponse(id=1091044, encodeId=2729109104488, content=highlights部分的一般要求是什么？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=bb142989248, createdName=MS68862005, createdTime=Wed Dec 29 14:52:48 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1091043, encodeId=ac5710910433f, content=什么时候需要highlights部分？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=107, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=1ff65466529, createdName=ms6000000264964247, createdTime=Tue Dec 28 14:52:48 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1057075, encodeId=cf46105e07545, content=审稿速度:1.0 | 投稿命中率:50.0 偏重的研究方向：心血管研究;心律失常 经验分享：我是基础心血管药理学研究，心律失常方向。一审三周多点，两个reviews给了半年的大修，意见很细致，从实验上到文字讨论问题都提到了，并且都给出了文献引用供作者修稿时参考，问题都很专业，直击要害。我修回以后又是三周直接接收，3-5天直接预先在杂志官网online并出现DOI号，7-10天可在Pubmed检索到并出现PMID。三周以后发proof让校稿。目前等待正式上线中。是否OA可自选，价钱不便宜。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=115, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=d4215515377, createdName=ms1000001131168263, createdTime=Sun Oct 03 10:25:37 CST 2021, time=2021-10-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=544016, encodeId=1cd75440160f, content=徘徊不前,不过处于这个关口上的期刊,再往上冲已不易了,4分多,也算满意了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=374, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=wang_di98, createdTime=Sun Jul 16 19:01:00 CST 2017, time=2017-07-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=832235, encodeId=859d832235be, content=审稿速度:2.0 经验分享：已修回，但修改意见特别多，三个审稿人，都提出了大量的问题。argue了整整9页。编辑和审稿人都很负责任。作为一个临床房颤的研究，还是挺受欢迎的。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=177, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=40eb5414087, createdName=ms8415407993286297, createdTime=Tue May 24 13:38:26 CST 2016, time=2016-05-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=500345, encodeId=39a850034588, content=屡投屡拒啊，伤心，但是继续坚持！！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=408, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Wed Dec 25 14:44:00 CST 2013, time=2013-12-25, status=1, ipAttribution=)]

2016-05-24 ms8415407993286297

审稿速度:2.0
经验分享：已修回，但修改意见特别多，三个审稿人，都提出了大量的问题。argue了整整9页。编辑和审稿人都很负责任。作为一个临床房颤的研究，还是挺受欢迎的。

177 0

[GetPortalCommentsPageByObjectIdResponse(id=1091044, encodeId=2729109104488, content=highlights部分的一般要求是什么？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=bb142989248, createdName=MS68862005, createdTime=Wed Dec 29 14:52:48 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1091043, encodeId=ac5710910433f, content=什么时候需要highlights部分？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=107, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=1ff65466529, createdName=ms6000000264964247, createdTime=Tue Dec 28 14:52:48 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1057075, encodeId=cf46105e07545, content=审稿速度:1.0 | 投稿命中率:50.0 偏重的研究方向：心血管研究;心律失常 经验分享：我是基础心血管药理学研究，心律失常方向。一审三周多点，两个reviews给了半年的大修，意见很细致，从实验上到文字讨论问题都提到了，并且都给出了文献引用供作者修稿时参考，问题都很专业，直击要害。我修回以后又是三周直接接收，3-5天直接预先在杂志官网online并出现DOI号，7-10天可在Pubmed检索到并出现PMID。三周以后发proof让校稿。目前等待正式上线中。是否OA可自选，价钱不便宜。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=115, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=d4215515377, createdName=ms1000001131168263, createdTime=Sun Oct 03 10:25:37 CST 2021, time=2021-10-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=544016, encodeId=1cd75440160f, content=徘徊不前,不过处于这个关口上的期刊,再往上冲已不易了,4分多,也算满意了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=374, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=wang_di98, createdTime=Sun Jul 16 19:01:00 CST 2017, time=2017-07-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=832235, encodeId=859d832235be, content=审稿速度:2.0 经验分享：已修回，但修改意见特别多，三个审稿人，都提出了大量的问题。argue了整整9页。编辑和审稿人都很负责任。作为一个临床房颤的研究，还是挺受欢迎的。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=177, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=40eb5414087, createdName=ms8415407993286297, createdTime=Tue May 24 13:38:26 CST 2016, time=2016-05-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=500345, encodeId=39a850034588, content=屡投屡拒啊，伤心，但是继续坚持！！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=408, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Wed Dec 25 14:44:00 CST 2013, time=2013-12-25, status=1, ipAttribution=)]

2013-12-25 匿名用户

屡投屡拒啊，伤心，但是继续坚持！！

408 0

内科

外科

专科科室

热点

按科室浏览

临床工具

科研工具

其他工具

科研数智化

真实世界研究解决方案

数字化学术传播解决方案

其它

期刊讨论

科室

工具

服务